Vimarsana
Biggest News Aggregation in the World

Page 14 - Device Designation News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Device Designation. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Device Designation Today - Breaking & Trending Today

Promis Diagnostics' EarlyTect BCD Receives FDA Breakthrough Device Designation for Bladder Cancer Detection - Vimarsana News

Promis Diagnostics' EarlyTect BCD Receives FDA Breakthrough Device Designation for Bladder Cancer Detection

/PRNewswire/ -- Promis Diagnostics, Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation to...

Global Multicancer Screening Market to Reach $7.78 Billion by 2032 - Exclusive DeepTech M-A-P™ Analysis by BIS Research - Vimarsana News

Global Multicancer Screening Market to Reach $7.78 Billion by 2032 - Exclusive DeepTech M-A-P™ Analysis by BIS Research

/PRNewswire/ -- BIS Research, the global leader in providing market intelligence on deep technologies, has released its latest study titled Multicancer...

Global Multicancer Screening Market to Reach $7.78 Billion by 2032 - Exclusive DeepTech M-A-P Analysis by BIS Research - Vimarsana News

Global Multicancer Screening Market to Reach $7.78 Billion by 2032 - Exclusive DeepTech M-A-P Analysis by BIS Research

New discoveries of specific biomarkers related to various cancer types are increasing researchers' trust in multicancer sequencing. FREMONT, Calif., April 28, 2023 /PRNewswire/ -- BIS Research

Ultromics receives Breakthrough Device Designation for AI cardiac amyloidosis tool and more digital health briefs - Vimarsana News

Ultromics receives Breakthrough Device Designation for AI cardiac amyloidosis tool and more digital health briefs

Click Therapeutics has begun a clinical trial for its episode migraine digital therapeutic, and Digital Diagnostics is offering its AI-backed diabetic retinopathy screening at select Labcorp locations.

CytoSorbents' Pivotal STAR-T Trial Reaches Second Key Milestone With 80 Patients Enrolled - Vimarsana News

CytoSorbents' Pivotal STAR-T Trial Reaches Second Key Milestone With 80 Patients Enrolled

PRINCETON, N.J., April 20, 2023 -- CytoSorbents Corporation , a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification via... | April 20, 2023